Ethics approval and consent to participate
T2DM
Sixty patients with T2DM (male and female) were recruited in this double-blind, randomized, controlled clinical trial from the Institute of Endocrinology and Metabolism, Iran university of Medical Sciences, Tehran, Iran. All methods were performed in accordance with relevant guidelines and regulations of Helsinki declaration. The Ethical Committee of Iran University of Medical Sciences approved the study protocol, and was registered on the Iranian Registry of Clinical Trials website (http://www.irct.ir, identifier: IRCT201410142709N31, at the date of 11/12/2014). Written informed consent was received from all participants before clinical trial enrollment.